PACIFIC BIOSCIENCES OF CALIF (PACB)

US69404D1081 - Common Stock

1.65  +0.05 (+3.12%)

Premarket: 1.66 +0.01 (+0.61%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
130.5M
65.40%		128.3M
-1.69%		200.521M
56.29%		243.6M
21.48%
EBITDA
YoY % growth
-171.72M
-75.28%		-293.11M
-70.69%		-302.265M
-3.12%		-269.98M
10.68%		N/AN/AN/AN/A
EBIT
YoY % growth
-179.3M
-71.74%		-303.5M
-69.27%		-321.989M
-6.09%		-292.194M
9.25%
Operating Margin
-137.39%-236.55%-160.58%-119.95%
EPS
YoY % growth
-1.20
-823.08%		-1.40
-16.67%		-1.21
13.57%		-1.05
12.89%		N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.28
21.97%
Revenue
Q2Q % growth		44.656M
14.80%
EBITDA
Q2Q % growth		-76.305MN/AN/AN/AN/A
EBIT
Q2Q % growth		-77.944M
14.58%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.31
16.22%		-0.29-0.02-6.56%
Q3 2023
Q2Q % growth		 -0.26
23.53%		-0.330.0722.31%
Q2 2023
Q2Q % growth		 -0.28
12.50%		-0.330.0514.39%
Q1 2023
Q2Q % growth		 -0.36
2.70%		-0.34-0.02-6.15%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 58.357M
113.37%		58.635M-278K-0.47%
Q3 2023
Q2Q % growth		 55.69M
72.36%		49.736M5.954M11.97%
Q2 2023
Q2Q % growth		 47.57M
34.11%		41.104M6.466M15.73%
Q1 2023
Q2Q % growth		 38.9M
17.27%		35.071M3.829M10.92%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-1.5% -2.34% -0.02% -3.06%
Revenue-12.9% -19% -0.08% -7.94%